Candidiasis: Clinical Trials

4 trials for Candidiasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 terminated. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Terminated 4

Follow Candidiasis: new trials by email Literature Review of Candidiasis trials Research Report on Candidiasis

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)
Caspofungin, Amphotericin B Deoxycholate - Candidiasis, Invasive
Phase 2TerminatedMerck Sharp & Dohme LLC512014-01-152019-11-25
Pilot Feasibility Study With Patients Who Are at High Risk For Developing Invasive Candidiasis in a Critical Care Setting (MK-0991-067)
Caspofungin acetate, Placebo - Invasive Candidiasis
Phase 2TerminatedMerck Sharp & Dohme LLC152010-12-012017-03-24
Anidulafungin in Patients With Hematologic Malignancies
Anidulafungin - Hematologic Malignancies
Phase 2TerminatedElisabethinen Hospital102009-10-012012-03-02
Safety and Effectiveness of Giving L-743,872 to Patients With Thrush That Has Not Been Cured With Fluconazole
L-743,872 - Candidiasis, Oral, HIV Infections
Phase 2TerminatedMerck Sharp & Dohme LLC702005-06-24

Narrower conditions

Candidiasis, Invasive (3)  ·  AIDS-Related Opportunistic Infections (1)  ·  Candidiasis, Oral (1)  ·  HIV Infections (1)  ·  Hematologic Neoplasms (1)  ·  Invasive Fungal Infections (1)  ·  Mycoses (1)  ·  Pharyngeal Diseases (1)

Broader conditions

Bacterial Infections and Mycoses (4)  ·  Infections (4)  ·  Mycoses (3)  ·  Invasive Fungal Infections (2)  ·  Blood-Borne Infections (1)  ·  Communicable Diseases (1)  ·  Genital Diseases (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Lentivirus Infections (1)  ·  Mouth Diseases (1)  ·  Neoplasms (1)

Interventions

Caspofungin (3)  ·  Anidulafungin (1)  ·  Saline Solution (1)  ·  amphotericin B, deoxycholate drug combination (1)

Sponsors

Merck Sharp & Dohme LLC (3)  ·  Elisabethinen Hospital (1)

Countries

Austria (1)  ·  United States (1)

Top investigators

Michael Girschikofsky, MD (1)

Results publications

PMID 31586424

NIH funding

2009 (1)